Editorial: Cancer diagnosis and novel drug discovery based on microbiome

Editorial: Cancer diagnosis and novel drug discovery based on microbiome

Bibliographic Details
Main Authors:	Peng Chen, Ge Zhang, Jianhui Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Microbiology
Subjects:	microbiome high throughput sequencing cancer diagnosis drug discovery
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1144986/full

Similar Items

Editorial: Integration of structural biology data in lead drug discovery and optimization
by: Pietro Roversi, et al.
Published: (2023-02-01)

Taxanorm: a novel taxa-specific normalization approach for microbiome data
by: Ziyue Wang, et al.
Published: (2024-09-01)

Application of Fluorescence- and Bioluminescence-Based Biosensors in Cancer Drug Discovery
by: Tynan Kelly, et al.
Published: (2024-11-01)

Breaking Barriers with Bread: Using the Sourdough Starter Microbiome to Teach High-Throughput Sequencing Techniques
by: Benjamin H. Holt, et al.
Published: (2022-08-01)

High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases
by: Hasan Aldewachi, et al.
Published: (2021-02-01)

The dynamic communities of oral microbiome in neonates
by: Haiying Guo, et al.
Published: (2022-12-01)

Adipocyte-based high throughput screening for anti-obesity drug discovery: Current status and future perspectives
by: Leo Tsui
Published: (2022-10-01)

Advances in high‐throughput mass spectrometry in drug discovery
by: Maria Emilia Dueñas, et al.
Published: (2023-01-01)

ZeOncoTest: Refining and Automating the Zebrafish Xenograft Model for Drug Discovery in Cancer
by: Carles Cornet, et al.
Published: (2019-12-01)

Epigenetic assays for chemical biology and drug discovery
by: Sheraz Gul
Published: (2017-04-01)

Notes on AEMS methods development for high throughput experimentation in drug discovery
by: Meghav Verma, et al.
Published: (2024-12-01)

Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies
by: Chamoné Munnik, et al.
Published: (2022-08-01)

Application of polymersomes in membrane protein study and drug discovery: Progress, strategies, and perspectives
by: Chih Hung Lo, et al.
Published: (2023-01-01)

Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery
by: Adam Michael Stewart, et al.
Published: (2015-02-01)

Endometrial and vaginal microbiome in donkeys with and without clinical endometritis
by: Jing Li, et al.
Published: (2022-08-01)

Characterization of the salivary microbiome in people with obesity
by: Yujia Wu, et al.
Published: (2018-03-01)

Discovery of Novel Anti-cryptosporidial Activities From Natural Products by in vitro High-Throughput Phenotypic Screening
by: Zi Jin, et al.
Published: (2019-08-01)

Optimizing depth and type of high‐throughput sequencing data for microsatellite discovery
by: Mark A. Chapman
Published: (2019-11-01)

Editorial: Newer initiatives in detection, drug discovery and therapeutic management of drug-resistant tuberculosis
by: Radha Gopalaswamy, et al.
Published: (2024-12-01)

Characterization of the oral and gut microbiome in children with obesity aged 3 to 5 years
by: Ting Ma, et al.
Published: (2023-03-01)

Editorial: Targeting ion channels for drug discovery: emerging challenges for high throughput screening technologies
by: Ciria C. Hernandez, et al.
Published: (2024-05-01)

Ultra-fast Generic LC-MS/MS Method for High-Throughput Quantification in Drug Discovery
by: So-Hee Kim, et al.
Published: (2013-09-01)

Behind the screen: drug discovery using the big data of phenotypic analysis
by: Merrill M. Froney, et al.
Published: (2024-02-01)

High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming
by: Lijun Huang, et al.
Published: (2021-10-01)

Shotgun metagenomic data of microbiomes on plastic fabrics exposed to harsh tropical environments
by: Osman Radwan, et al.
Published: (2020-10-01)

Editorial: Zebrafish as a model for pharmacological and toxicological research
by: Carla Denise Bonan, et al.
Published: (2022-08-01)

Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities
by: Dachao Liang, et al.
Published: (2018-01-01)

Ex vivo discovery of synergistic drug combinations for hematologic malignancies
by: Kamran A. Ali, et al.
Published: (2024-03-01)

High-throughput screening in drug discovery /
by: Huser, Jorg
Published: (2006)

Discovery of antimicrobial compounds targeting bacterial type FAD synthetases
by: María Sebastián, et al.
Published: (2018-01-01)

The Skin Microbiome of Cohabiting Couples
by: Ashley A. Ross, et al.
Published: (2017-08-01)

Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4
by: Dorian M. Cheff, et al.
Published: (2023-07-01)

Characterization of the blood and neutrophil‐specific microbiomes and exploration of potential bacterial biomarkers for sepsis in surgical patients
by: Chenyang Wang, et al.
Published: (2021-12-01)

Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma
by: André Serra-Roma, et al.
Published: (2020-04-01)

Vertical transfer and functional characterization of cotton seed core microbiome
by: Chongdie Wu, et al.
Published: (2024-01-01)

Discovery of Novel Integrase Inhibitors Acting outside the Active Site Through High-Throughput Screening
by: Cindy Aknin, et al.
Published: (2019-10-01)

Unprecedented Potential for Neural Drug Discovery Based on Self-Organizing hiPSC Platforms
by: Agustín Cota-Coronado, et al.
Published: (2020-03-01)

Dysbiosis of saliva microbiome in patients with oral lichen planus
by: Fei Yan Yu, et al.
Published: (2020-04-01)

The Application of High-Throughput Technologies for the Study of Microbiome and Cancer
by: Lu Qi Wei, et al.
Published: (2021-07-01)

Editorial: The role of genes and network pharmacology in new drug discovery
by: Jingxin Mao, et al.
Published: (2025-03-01)